13F-HR filed by Boxer Capital, LLC
Boxer Capital, LLC filed this 13F-HR for the quarter ended 2020-12-31, filed 2021-02-16, with 78 holding rows worth $3,110,957,000.
- Accession
- 0000950123-21-002862
- Filer
- CIK 1465837
- Filed
- 2021-02-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2020
A holdings report, 78 entries on the cover page, a total value of $3,110,957,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,110,957,000 with VALUE read as thousands by filing date, 13F file number 028-17339. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 1,765,560 | $387,788,000 | thousands by filing date | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 1,114,188 | $287,895,000 | thousands by filing date | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 2,075,905 | $150,545,000 | thousands by filing date | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 4,345,016 | $146,948,000 | thousands by filing date | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 2,268,236 | $139,519,000 | thousands by filing date | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 3,309,264 | $131,014,000 | thousands by filing date | |
| ODONATE THERAPEUTICS INC | 676079106 | COM | 5,607,086 | $107,656,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 1,094,000 | $94,642,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 1,466,051 | $80,398,000 | thousands by filing date | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 1,675,377 | $77,637,000 | thousands by filing date | |
| SEATTLE GENETICS INC | 812578102 | COM | 400,000 | $70,056,000 | thousands by filing date | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 2,014,858 | $64,576,000 | thousands by filing date | |
| DIREXION SHS ETF TR | 25460G716 | DAILY S&P BIOTEC | 2,250,000 | $56,858,000 | thousands by filing date | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 2,084,883 | $54,124,000 | thousands by filing date | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 1,294,132 | $53,784,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 2,325,000 | $53,684,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 2,287,782 | $50,880,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 170,926 | $50,268,000 | thousands by filing date | |
| PASSAGE BIO INC | 702712100 | COM | 1,928,315 | $49,307,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 2,100,000 | $43,638,000 | thousands by filing date | |
| KINNATE BIOPHARMA INC | 49705R105 | COM | 1,064,665 | $42,352,000 | thousands by filing date | |
| ALIGOS THERAPEUTICS INC COM NEW | 01626L105 | Stock | 1,526,048 | $42,195,000 | thousands by filing date | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 1,224,892 | $40,274,000 | thousands by filing date | |
| ATRECA INC | 04965G109 | COM | 2,202,333 | $35,568,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 1,050,289 | $34,302,000 | thousands by filing date | |
| SOLID BIOSCIENCES INC COM NEW | 83422E105 | Stock | 4,234,574 | $32,098,000 | thousands by filing date | |
| PANDION THERAPEUTICS INC | 698340106 | COM | 2,107,513 | $31,297,000 | thousands by filing date | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 2,202,812 | $30,839,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 6,000,000 | $29,340,000 | thousands by filing date | |
| MARINUS PHARMACEUTICALS INC | 56854Q200 | COM NEW | 2,400,000 | $29,280,000 | thousands by filing date | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 1,121,327 | $28,616,000 | thousands by filing date | |
| ANAPTYSBIO INC | 032724106 | COM | 1,300,000 | $27,950,000 | thousands by filing date | |
| PREVAIL THERAPEUTICS INC | 74140Y101 | COM | 1,123,105 | $25,910,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 6,205,882 | $25,754,000 | thousands by filing date | |
| MERUS N V | N5749R100 | COM | 1,427,849 | $25,030,000 | thousands by filing date | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 2,562,358 | $24,778,000 | thousands by filing date | |
| BIOATLA INC | 09077B104 | COM | 686,347 | $23,343,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 4,000,000 | $22,960,000 | thousands by filing date | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 6,226,673 | $22,291,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 250,000 | $21,923,000 | thousands by filing date | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 831,495 | $21,453,000 | thousands by filing date | |
| NEOLEUKIN THERAPEUTICS INC | 64049K104 | COM | 1,501,058 | $21,165,000 | thousands by filing date | |
| THERAPEUTICS ACQUISITION COR | 88339T103 | COM CL A | 1,500,000 | $20,880,000 | thousands by filing date | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 1,603,361 | $20,010,000 | thousands by filing date | |
| CODIAK BIOSCIENCES INC | 192010106 | COM | 602,650 | $19,466,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 1,000,000 | $17,520,000 | thousands by filing date | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 2,477,194 | $16,597,000 | thousands by filing date | |
| MATINAS BIOPHARMA HLDGS INC | 576810105 | COM | 11,478,634 | $15,611,000 | thousands by filing date | |
| POSEIDA THERAPEUTICS INC | 73730P108 | COM | 1,251,055 | $13,724,000 | thousands by filing date | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 7,534,598 | $13,035,000 | thousands by filing date | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 500,000 | $13,000,000 | thousands by filing date | |
| AGENUS INC | 00847G705 | COM NEW | 4,000,000 | $12,720,000 | thousands by filing date | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 714,500 | $11,846,000 | thousands by filing date | |
| SPECTRUM PHARMACEUTICALS INC | 84763A108 | COM | 3,333,333 | $11,367,000 | thousands by filing date | |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 3,284,072 | $9,951,000 | thousands by filing date | |
| PANACEA ACQUISITION CORP | 698102100 | CL A | 800,000 | $9,360,000 | thousands by filing date | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 2,975,000 | $9,104,000 | thousands by filing date | |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 1,500,000 | $9,075,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 250,000 | $9,033,000 | thousands by filing date | |
| FS DEV CORP | 303020101 | COM CL A | 700,000 | $7,700,000 | thousands by filing date | |
| MEI PHARMA INC | 55279B202 | COM NEW | 2,913,091 | $7,691,000 | thousands by filing date | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 200,000 | $6,770,000 | thousands by filing date | |
| ARYA SCIENCES ACQUISTION CO | G31655122 | COM CL A | 600,000 | $6,510,000 | thousands by filing date | |
| VINCERX PHARMA INC | 92731L106 | COM NEW | 300,000 | $6,273,000 | thousands by filing date | |
| BCLS ACQUISITION CORP | G0904B105 | CMN | 500,000 | $6,005,000 | thousands by filing date | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 317,000 | $5,535,000 | thousands by filing date | |
| JIYA ACQUISITION CORP | 47760M102 | CMN | 500,000 | $5,150,000 | thousands by filing date | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 290,577 | $5,134,000 | thousands by filing date | |
| HEALTH SCIENCES ACQ CORP 2 | G4411D109 | ORD SHS | 400,000 | $5,124,000 | thousands by filing date | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 209,227 | $5,065,000 | thousands by filing date | |
| MOONLAKE IMMUNOTHERAPEUTICS | G4444C102 | COM | 400,000 | $4,548,000 | thousands by filing date | |
| AEGLEA BIOTHERAPEUTICS INC | 00773J103 | COM | 550,000 | $4,329,000 | thousands by filing date | |
| LA JOLLA PHARMACEUTICAL CO | 503459604 | COM PAR $.0001 2 | 890,700 | $3,456,000 | thousands by filing date | |
| GENOCEA BIOSCIENCES INC | 372427401 | COMMON STOCK | 1,134,453 | $2,745,000 | thousands by filing date | |
| LIFESCI ACQUISITION II CORP | 53229E103 | COM | 200,000 | $2,134,000 | thousands by filing date | |
| CONSONANCE HFW ACQUISITION C | G2445M129 | UNIT 99/99/9999 | 200,000 | $2,094,000 | thousands by filing date | |
| CELLECTAR BIOSCIENCES INC | 15117F500 | COM PAR | 920,000 | $1,914,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 27,300 | $546,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-21-002862 | this filing | 2021-02-16 | acceptance time not in the bulk data set |